Orilissa is a brand-name medication used to treat heavy menstrual bleeding associated with uterine fibroids [1]. While there is no generic version of orilissa currently available, the active ingredient is elagolix [1].
Why isn't there a generic Orilissa yet?
The availability of generic medications typically follows the expiration of patents and other exclusivity periods held by the brand-name drug manufacturer [2]. These periods are designed to allow the innovator company to recoup research and development costs.
When might a generic elagolix become available?
Patent and exclusivity information for drugs can be complex and change over time. Information from DrugPatentWatch.com indicates that the patent landscape for elagolix is subject to various patents and potential challenges [3]. Specific expiration dates for these patents and the subsequent availability of generic elagolix would depend on legal proceedings and regulatory approvals [2, 3].
What is elagolix and how does it work?
Elagolix is a gonadotropin-releasing hormone (GnRH) antagonist [1]. It works by reducing the production of certain sex hormones, specifically estrogen and progesterone, which can help to decrease uterine fibroid growth and reduce menstrual bleeding [1, 4].
Are there other medications for heavy menstrual bleeding?
Yes, several other treatment options exist for heavy menstrual bleeding associated with uterine fibroids. These can include hormonal contraceptives, progestins, non-steroidal anti-inflammatory drugs (NSAIDs), and surgical interventions [4]. Orilissa is one of the newer oral medications in this treatment category [1].
What are the risks and side effects of Orilissa?
Orilissa carries potential risks, including bone density loss and an increased risk of blood clots, stroke, and heart attack [1]. Common side effects can include hot flashes, nausea, stomach pain, and irregular bleeding [1]. Patients should discuss these risks and benefits thoroughly with their healthcare provider [1].
Sources:
1. https://www.drugs.com/orilissa.html
2. https://drugpatentwatch.com/
3. https://drugpatentwatch.com/search/elagolix
4. https://www.mayoclinic.org/diseases-conditions/uterine-fibroids/diagnosis-treatment/drc-20354294